.�this negligence must not be allowed to continue,� budkie�s letter states. �the university of california, berkeley, has clearly failed to follow federal regulations and guidelines.� . . . . january 2006 (14) . .biohaven: "rimegepant pivotal phase 3 trial results -- conference call." .